Attach to Form 990 or Form 990-EZ.
Go to
www.irs.gov/Form990 for instructions and the latest information.
| (i) Name of supported organization | (ii) EIN | (iii) Type of organization (described on lines 1- 10 above (see instructions)) | (iv) Is the organization listed in your governing document? | (v) Amount of monetary support (see instructions) | (vi) Amount of other support (see instructions) | |
|---|---|---|---|---|---|---|
| Yes | No | |||||
|
Total |
||||||
Calendar year
(or fiscal year beginning in)
![]() |
(a) 2018 | (b) 2019 | (c) 2020 | (d) 2021 | (e) 2022 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grant.") .. | 16,279,595 | 12,226,058 | 10,837,807 | 12,273,935 | 10,094,745 | 61,712,140 |
| 2 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf.... | ||||||
| 3 | The value of services or facilities furnished by a governmental unit to the organization without charge.. | ||||||
| 4 | Total. Add lines 1 through 3 | 16,279,595 | 12,226,058 | 10,837,807 | 12,273,935 | 10,094,745 | 61,712,140 |
| 5 | The portion of total contributions by each person (other than a governmental unit or publicly supported organization) included on line 1 that exceeds 2% of the amount shown on line 11, column (f) .. | 5,341,050 | |||||
| 6 | Public support. Subtract line 5 from line 4. | 56,371,090 | |||||
Calendar year
(or fiscal year beginning in)
![]() |
(a) 2018 | (b) 2019 | (c) 2020 | (d) 2021 | (e) 2022 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 7 | Amounts from line 4.. | 16,279,595 | 12,226,058 | 10,837,807 | 12,273,935 | 10,094,745 | 61,712,140 |
| 8 | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources... | 489,512 | 240,918 | 208,468 | 275,814 | 237,474 | 1,452,186 |
| 9 | Net income from unrelated business activities, whether or not the business is regularly carried on.. | ||||||
| 10 | Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.).. | 46,605 | 253,743 | 1,555,351 | 203,990 | 155,338 | 2,215,027 |
| 11 | Total support. Add lines 7 through 10 | 65,379,353 | |||||
Calendar year (or fiscal year beginning in) ![]() |
(a) 2018 | (b) 2019 | (c) 2020 | (d) 2021 | (e) 2022 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grants.") . | ||||||
| 2 | Gross receipts from admissions, merchandise sold or services performed, or facilities furnished in any activity that is related to the organization's tax-exempt purpose | ||||||
| 3 | Gross receipts from activities that are not an unrelated trade or business under section 513 ..... | ||||||
| 4 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf... | ||||||
| 5 | The value of services or facilities furnished by a governmental unit to the organization without charge | ||||||
| 6 | Total. Add lines 1 through 5 | ||||||
| 7a | Amounts included on lines 1, 2, and 3 received from disqualified persons | ||||||
| b | Amounts included on lines 2 and 3 received from other than disqualified persons that exceed the greater of $5,000 or 1% of the amount on line 13 for the year. | ||||||
| c | Add lines 7a and 7b.. | ||||||
| 8 | Public support. (Subtract line 7c from line 6.) | ||||||
Calendar year (or fiscal year beginning in) ![]() |
(a) 2018 | (b) 2019 | (c) 2020 | (d) 2021 | (e) 2022 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 9 | Amounts from line 6... | ||||||
| 10a | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources.. | ||||||
| b | Unrelated business taxable income (less section 511 taxes) from businesses acquired after June 30, 1975. | ||||||
| c | Add lines 10a and 10b. | ||||||
| 11 | Net income from unrelated business activities not included on line 10b, whether or not the business is regularly carried on. | ||||||
| 12 | Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.) .. | ||||||
| 13 | Total support. (Add lines 9, 10c, 11, and 12.).. | ||||||
| Section A - Adjusted Net Income | (A) Prior Year |
(B) Current Year (optional) |
||||
| 1 | Net short-term capital gain | 1 | ||||
| 2 | Recoveries of prior-year distributions | 2 | ||||
| 3 | Other gross income (see instructions) | 3 | ||||
| 4 | Add lines 1 through 3 | 4 | ||||
| 5 | Depreciation and depletion | 5 | ||||
| 6 | Portion of operating expenses paid or incurred for production or collection of gross income or for management, conservation, or maintenance of property held for production of income (see instructions) | 6 | ||||
| 7 | Other expenses (see instructions) | 7 | ||||
| 8 | Adjusted Net Income (subtract lines 5, 6 and 7 from line 4) | 8 | ||||
| Section B - Minimum Asset Amount | (A) Prior Year |
(B) Current Year (optional) |
||||
| 1 | Aggregate fair market value of all non-exempt-use assets (see instructions for short tax year or assets held for part of year): | 1 | ||||
| a | Average monthly value of securities | 1a | ||||
| b | Average monthly cash balances | 1b | ||||
| c | Fair market value of other non-exempt-use assets | 1c | ||||
| d | Total (add lines 1a, 1b, and 1c) | 1d | ||||
| e |
Discount claimed for blockage or other factors (explain in detail in Part VI): |
|||||
| 2 | Acquisition indebtedness applicable to non-exempt use assets | 2 | ||||
| 3 | Subtract line 2 from line 1d | 3 | ||||
| 4 | Cash deemed held for exempt use. Enter 0.015 of line 3 (for greater amount, see instructions). | 4 | ||||
| 5 | Net value of non-exempt-use assets (subtract line 4 from line 3) | 5 | ||||
| 6 | Multiply line 5 by 0.035 | 6 | ||||
| 7 | Recoveries of prior-year distributions | 7 | ||||
| 8 | Minimum Asset Amount (add line 7 to line 6) | 8 | ||||
| Section C - Distributable Amount | Current Year | |||||
| 1 | Adjusted net income for prior year (from Section A, line 8, Column A) | 1 | ||||
| 2 | Enter 85% of line 1 | 2 | ||||
| 3 | Minimum asset amount for prior year (from Section B, line 8, Column A) | 3 | ||||
| 4 | Enter greater of line 2 or line 3 | 4 | ||||
| 5 | Income tax imposed in prior year | 5 | ||||
| 6 | Distributable Amount. Subtract line 5 from line 4, unless subject to emergency temporary reduction (see instructions) | 6 | ||||
| Section D - Distributions | Current Year | |
|---|---|---|
| 1 Amounts paid to supported organizations to accomplish exempt purposes | 1 | |
|
2
Amounts paid to perform activity that directly furthers exempt purposes of supported organizations, in excess of income from activity |
2 | |
| 3 Administrative expenses paid to accomplish exempt purposes of supported organizations | 3 | |
| 4 Amounts paid to acquire exempt-use assets | 4 | |
| 5 Qualified set-aside amounts (prior IRS approval required - provide details in Part VI) | 5 | |
| 6 Other distributions (describe in Part VI). See instructions | 6 | |
| 7Total annual distributions. Add lines 1 through 6. | 7 | |
|
8
Distributions to attentive supported organizations to which the organization is responsive (provide details in Part VI). See instructions |
8 | |
| 9 Distributable amount for 2022 from Section C, line 6 | 9 | |
| 10 Line 8 amount divided by Line 9 amount | 10 | |
| Section E - Distribution Allocations (see instructions) |
(i) Excess Distributions |
(ii) Underdistributions Pre-2022 |
(iii) Distributable Amount for 2022 |
|
|---|---|---|---|---|
| 1 Distributable amount for 2022 from Section C, line 6 | ||||
|
2
Underdistributions, if any, for years prior to 2022 (reasonable cause required-- explain in Part VI).
See instructions. |
||||
| 3 Excess distributions carryover, if any, to 2022: | ||||
| a From 2017....... | ||||
| b From 2018....... | ||||
| c From 2019....... | ||||
| d From 2020....... | ||||
| e From 2021....... | ||||
| fTotal of lines 3a through e | ||||
| g Applied to underdistributions of prior years | ||||
| h Applied to 2022 distributable amount | ||||
|
i
Carryover from 2017 not applied (see instructions) |
||||
| j Remainder. Subtract lines 3g, 3h, and 3i from line 3f. | ||||
| 4Distributions for 2022 from Section D, line 7: | ||||
| $ | ||||
| a Applied to underdistributions of prior years | ||||
| b Applied to 2022 distributable amount | ||||
| c Remainder. Subtract lines 4a and 4b from line 4. | ||||
|
5
Remaining underdistributions for years prior to 2022, if any. Subtract lines 3g and 4a from line 2. If the amount is greater than zero, explain in Part VI. See instructions. |
||||
|
6
Remaining underdistributions for 2022. Subtract lines 3h and 4b from line 1. If the amount is greater than zero, explain in Part VI. See instructions. |
||||
|
7 Excess distributions carryover to 2023. Add lines 3j and 4c. |
||||
| 8 Breakdown of line 7: | ||||
| a Excess from 2018..... | ||||
| b Excess from 2019..... | ||||
| c Excess from 2020..... | ||||
| d Excess from 2021..... | ||||
| e Excess from 2022..... | ||||
| Facts And Circumstances Test |
|---|
| Return Reference | Explanation |
|---|---|
| SCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME: | OTHER INCOME - 2018 AMOUNT: $ 46,605. 2019 AMOUNT: $ 253,743. 2020 AMOUNT: $ 1,555,351. 2021 AMOUNT: $ 203,990. 2022 AMOUNT: $ 155,338. |
| Software ID: | |
| Software Version: |
Attach to Form 990 or 990-EZ.
Go to www.irs.gov/Form990 for the latest information.
| Return Reference | Explanation |
|---|---|
| FORM 990, PART III, LINE 4A, CONTINUED. | CANCER HEALTH CHECK AN ONLINE ASSESSMENT TOOL TO HELP INDIVIDUALS UNDERSTAND HOW THE LIFESTYLE CHOICES THEY MAKE EVERY DAY CAN REDUCE THEIR RISK FOR CANCER. THIS SIMPLE AND EASY TOOL MEASURES INDIVIDUAL LIFESTYLE CHOICES, LIKE DIET AND EXERCISE HABITS, AGAINST AICR'S EVIDENCE-BASED 10 CANCER PREVENTION RECOMMENDATIONS. AFTER USERS ANSWER A BRIEF SERIES OF QUESTIONS, THEY IMMEDIATELY RECEIVE A SUMMARY OF RESULTS THAT SHOW AREAS WHERE THEY ARE DOING WELL AND WHERE THERE ARE AREAS FOR IMPROVEMENT. THIS IS AN APPROACHABLE TOOL THAT IS USED BY BOTH THE GENERAL PUBLIC AND BY HEALTH-CARE PROVIDERS. THIS INNOVATIVE TOOL LAUNCHED IN FEBRUARY 2020 WAS AWARDED GOLD/FIRST PLACE IN THE DIGITAL HEALTH RESOURCES/TOOL CATEGORY IN THE 2020 FALL DIGITAL HEALTH AWARDS. THERE WAS A TOTAL OF 15,918 USERS/E-MAILS COLLECTED IN FY2023 LIVING WITH CANCER AND BEYOND: CANCER RESOURCE PROGRAM AICR OFFERS A FREE BOOKLET OF ADVICE FOR NEWLY DIAGNOSED CANCER PATIENTS AND THEIR LOVED ONES. DEVELOPED WITH A TEAM OF PHYSICIANS, NURSES, DIETITIANS, PSYCHOLOGISTS AND CANCER PATIENTS, CANCER RESOURCE LAYS OUT INFORMATION PATIENTS NEED, INCLUDING QUESTIONS TO ASK YOUR DOCTOR, TREATMENT OPTIONS, WHERE TO FIND HELP, NUTRITION DURING TREATMENT AND MUCH MORE. AICR STAFF CAN CREATE CUSTOMIZED PACKETS FOR ANY CANCER BY INCLUDING SPECIFIC, DETAILED AND UP-TO-DATE PRINTOUTS ABOUT THE RELEVANT CANCER. REQUESTS FOR EACH PACKET ARE FILLED IMMEDIATELY TO GET THIS VITAL INFORMATION TO THOSE WHO NEED IT AS QUICKLY AS POSSIBLE. CANCER RESOURCE IS ALSO AVAILABLE IN SPANISH, WHICH INCREASES ACCESS TO THIS INFORMATION EVEN FURTHER AS A FREE DOWNLOADABLE ON AICR'S ONLINE STORE. IN FY23 THERE WERE A TOTAL OF 172 DOWNLOADS OF CANCER RESOURCE IN SPANISH, 4 DOWNLOADS IN ENGLISH AND 128 CANCER RESOURCE BOOKS WERE SOLD IN FY23. AICR'S HEALTH PROFESSIONAL AND EDUCATOR COMMUNITY AICR'S HP COMMUNITY PROVIDES AN ONLINE DESTINATION FOR HEALTH PROFESSIONALS, FEATURING A WEALTH OF INTERACTIVE TOOLS, CONTINUING EDUCATION OPPORTUNITIES AND PRACTICAL EVIDENCE-BASED RESOURCES FOR PATIENTS AND CLIENTS. PROGRAMS FOR CANCER SURVIVORS THE OVERALL AGING OF THE UNITED STATES POPULATION AND CHANGING PREVALENCE OF RISK FACTORS, INCLUDING OBESITY, HAVE INCREASED THE INCIDENCE OF MANY TYPES OF CANCER WHILE ADVANCES IN THE EARLY DETECTION AND TREATMENT OF CANCER HAVE LED TO REDUCED CANCER MORTALITY. THESE FACTORS HAVE COMBINED TO DRAMATICALLY INCREASE THE NUMBER OF CANCER SURVIVORS. NEARLY 18.3 MILLION PEOPLE IN THE US WERE LIVING WITH A HISTORY OF A CANCER DIAGNOSIS AS OF JANUARY 2022. THIS NUMBER IS PROJECTED TO GROW TO MORE THAN 26 MILLION BY 2040. DURING FY23, AICR PROACTIVELY FUNDED RESEARCH, DEVELOPED EVIDENCE-BASED INFORMATION AND CONTRIBUTED TOOLS, RESOURCES AND PROGRAMS THAT ARE ATTUNED TO THIS GROWING POPULATION. THE NEW AMERICAN PLATE COOKBOOK TO PLACE AICR'S MESSAGE ABOUT LOWERING CANCER RISK IN A COMPREHENSIVE AND HANDSOMELY PRODUCED FORMAT, AICR'S NEW AMERICAN PLATE COOKBOOK (PUBLISHED BY THE UNIVERSITY OF CALIFORNIA PRESS) IS AVAILABLE IN BOOKSTORES. ALMOST 35,000 COPIES HAVE BEEN SOLD, AND ALL ROYALTIES SUPPORT AICR CANCER RESEARCH. CONFERENCES AND EXHIBITS IN FY23, AICR STAFF ATTENDED, PRESENTED, NETWORKED, EXHIBITED AND/OR DISTRIBUTED MATERIALS AT VARIOUS VIRTUAL CONFERENCES AND ANNUAL MEETINGS. EXTERNAL RELATIONS IN FY23, AICR BUILT DEEPER RELATIONSHIPS WITH KEY NATIONAL, REGIONAL AND LOCAL STAKEHOLDER ORGANIZATIONS TO LEVERAGE THESE PARTNERSHIPS AND ENSURE OUR EVIDENCE-BASED MESSAGES AND EDUCATIONAL RESOURCES ARE UNDERSTOOD AND UTILIZED. AICR PROACTIVELY JOINED ADDITIONAL ORGANIZATIONS' COMMITTEES AND SERVED ON ADVISORY PANELS, WORK GROUPS AND EXPERT FORUMS TO BUILD VISIBILITY AND AWARENESS OF OUR MISSION. MEDIA PROGRAM AICR HAD SOLID MEDIA COVERAGE IN NATIONAL PRINT AND ONLINE OUTLETS AS WELL AS TV AND RADIO STATIONS. |
| FORM 990, PART III, LINE 4B, CONTINUED. | ON OCTOBER 13, 2022, THE CUP WAS RELAUNCHED DURING A WEBINAR THAT PRESENTED THE REFOCUSED GLOBAL CANCER UPDATE PROGRAM (CUP-GLOBAL), INTRODUCED THE NEW CUP GLOBAL PANEL INCLUDING PROFESSOR LORD JOHN KREBS AND PROFESSOR MATTY WEIJENBERG (THE NEW GLOBAL CANCER UPDATE PROGRAM PANEL CHAIR AND DEPUTY CHAIR, RESPECTIVELY), OUTLINED THE ROLE OF THE EXPERT COMMITTEES AND HIGHLIGHTED THE KEY GOALS AND PRIORITIES FOR THIS NEW AND EXCITING FUTURE FOR OUR FLAGSHIP RESEARCH PROGRAM. AICR ANNUAL RESEARCH CONFERENCE THE 2022 AICR RESEARCH CONFERENCE: DIET, OBESITY, PHYSICAL ACTIVITY AND CANCER WAS HELD OCTOBER 31 TO NOVEMBER 2, 2022, AT THE LANSDOWNE RESORT & SPA IN LEESBURG, VA. THE 2022 RESEARCH CONFERENCE WAS A HYBRID EVENT WITH BOTH A FULLY VIRTUAL OPTION AND AN IN-PERSON PROGRAM. KEYNOTE ADDRESS: DAVID ROBERT GRIMES, PHD: STEMMING A RISING TIDE OF CANCER MISINFORMATION PLENARY SESSIONS: TRUSTED SOURCES: COMBATTING MISINFORMATION THROUGH EFFECTIVE EVIDENCE-BASED COMMUNICATION ENHANCING CANCER THERAPY THROUGH CONVERGING INNOVATIONS IN LIFESTYLE AND ONCOLOGY RESEARCH THE ROLE OF LIFESTYLE IN ELEVATED GENETIC RISK DEVELOPING AND IMPLEMENTING CANCER PREVENTION, TREATMENT AND SURVIVORSHIP GUIDELINES SPEAKERS AND TOPICS: SYLVIA CHOU, PHD, MPH: COMBATTING CANCER MISINFORMATION IN A COMPLEX COMMUNICATION ECOSYSTEM DR. ROBERT MILLER, MD, FACP, FASCO, FAMIA: ONE-TO-ONE AND ONE-TO-MANY: AN ONCOLOGIST'S ROLE IN CONFRONTING CANCER MISINFORMATION KAREN BASEN-ENGQUIST, PHD, MPH: ACTIVE LIVING AFTER CANCER, A PHYSICAL ACTIVITY PROGRAM FOR CANCER SURVIVORS PARTNERING WITH COMMUNITY ORGANIZATIONS SAMUEL ORANGE, PHD: FEASIBILITY OF HOME-BASED, VIRTUALLY DELIVERED, GROUP EXERCISE FOR OLDER PATIENTS WITH PRIMARY LIVER CANCER (TELEX-LIVER CANCER): INTERIM ANALYSIS SCHEREZADE MAMA, DRPH: DESIGNING A MULTICOMPONENT PHYSICAL ACTIVITY INTERVENTION TO MEET THE UNIQUE NEEDS OF RURAL CANCER SURVIVORS UNDERGOING RADIATION THERAPY NEIL IYENGAR, MD AND RICHARD SIMPSON, PHD, FACSM: ENHANCING CANCER THERAPY THROUGH CONVERGING INNOVATIONS IN LIFESTYLE AND ONCOLOGY RESEARCH JUSTIN BROWN, PHD: ADAPTIVE RANDOMIZATION OF AEROBIC EXERCISE DURING CHEMOTHERAPY FOR COLON CANCER GRAEME KOELWYN, PHD, MS: HEART DISEASE AND CANCER: A TWO-WAY RELATIONSHIP LEWIS CANTLEY, MD, PHD: DIETARY INTERVENTION TO IMPROVE CANCER THERAPY JESSICA FESSLER, PHD: TARGETING THE MICROBIOTA-IMMUNE AXIS THROUGH DIET TO IMPROVE CANCER IMMUNOTHERAPY GERARDO MACKENZIE, PHD: LIVER SAFETY PROFILE OF A KETOGENIC DIET IN COMBINATION WITH GEMCITABINE IN PANCREATIC TUMOR-BEARING MICE ADAM NELCZYK, MS: FRIED CURED BACON AND HISTAMINERGIC SIGNALING: NOVEL INSIGHTS INTO THE IMPACT OF DIET ON THE DORMANT BREAST CANCER MICROENVIRONMENT ALANA ARNONE, MS: ENDOCRINE-TARGETING THERAPY SHIFTS THE BREAST MICROBIOME TO REDUCE ESTROGEN-RECEPTOR-A BREAST CANCER RISK CORNELIA ULRICH, PHD: PRECISION EXERCISE INTERVENTION IN PRIMARY AND SECONDARY LUNG CANCER PATIENTS UNDERGOING SURGERY: RESULTS FROM A PHASE III PEP STUDY TRIAL CHELSEA GOODENOUGH, PHD: BIOMARKERS OF CELLULAR SENESCENCE AND INFLAMMATION ASSOCIATED WITH EXERCISE CAPACITY AMONG ADULT SURVIVORS OF CHILDHOOD CANCER HEMANGI MAVADIYA, RD: RACIAL DISPARITY IN DIET RELATED PERCEPTIONS AND BEHAVIORS AMONG CANCER SURVIVORS KRISTY BROWN, PHD, AND CARRIE DANIEL-MACDOUGALL, PHD, MPH: THE ROLE OF LIFESTYLE IN ELEVATED GENETIC RISK LORELEI MUCCI, SCD: CAN THE INHERITED SUSCEPTIBILITY OF PROSTATE CANCER BE MODIFIED? (VIRTUAL) KRISTY A. BROWN, PHD: OBESITY IN BRCA MUTATION CARRIERS - PENETRATING INSIGHTS FROM MECHANISTIC STUDIES EDUARDO VILAR-SANCHEZ, MD, PHD: EXERCISE FOR CANCER PREVENTION IN LYNCH SYNDROME PATIENTS (VIRTUAL) JUSTIN GREGG, MD: COFFEE INTAKE, CAFFEINE METABOLISM GENOTYPE, AND SURVIVAL AMONG MEN WITH PROSTATE CANCER GABE CANALES: PATIENT ADVOCATES - AGENTS FOR CHANGE IN CANCER CARE AND RESEARCH DAWN MUSSALLEM, DO: THE EVOLVING ROLE FOR PATIENT ADVOCATES IN EVERY PHASE OF LIFESTYLE-RELATED CANCER RESEARCH WENDY K.D. SELIG, MS: IMPLEMENTATION OF PATIENT INVOLVEMENT IN CLINICAL CANCER RESEARCH: A PHILANTHROPIC FUNDERS APPROACH KAREN COLLINS, MS, RDN, CDN, FAND: DIETARY PATTERN RESEARCH AND RECOMMENDATIONS - EVIDENCE, GAP, AND COMMUNICATION SHERRY SHEN, MD: INSULIN-LOWERING DIETS: KETO AND LOW-CARBOHYDRATE DIETARY PATTERNS (VIRTUAL) ESTHER FARLEY, RN: PLANT-BASED DIETARY PATTERNS IN CANCER INCIDENCE AND MORTALITY - IMPACT AND CHALLENGES CLIFF HUDIS, MD: THE ROLE OF PROFESSIONAL SOCIETIES IN REDUCING CANCER RISK MARYAM LUSTBERG, MD, MPH: OPTIMIZING CANCER SURVIVORSHIP CARE DELIVERY: HOW CAN WE DO BETTER? ANN PARTRIDGE, MD, MPH: HARNESSING TECHNOLOGY IN PATIENT CENTERED CANCER CARE AICR TOWNHALL AICR HOSTED A TOWNHALL FOR PUBLIC ENGAGEMENT. DR. ETAN ORGEL AND DR. DAWN MUSSALLEM WERE THE FEATURED SPEAKERS FOR THE MEETING ON JUNE 14, 2023. EXTERNAL EVENTS AICR VP OF RESEARCH PRESENTED A GUEST LECTURE ON "NUTRITION AND CANCER - DISTINGUISHING EVIDENCE FROM OPINION IN CANCER PREVENTION AND SURVIVORSHIP" FOR THE NUTR305 COURSE, TUFTS UNIVERSITY, BOSTON, NOVEMBER 9, 2022. AICR VP OF RESEARCH PRESENTED A POST-CONFERENCE WORKSHOP ON "CANCER PREVENTION AND SURVIVORSHIP - TRANSLATING EVIDENCE TO EFFECTIVE LIFESTYLE MEDICINE PROGRAMS" AT THE AMERICAN COLLEGE OF LIFESTYLE MEDICINE CONFERENCE, ORLANDO, NOVEMBER 16, 2022. AICR VP OF RESEARCH PARTICIPATED IN THE ROUND TABLE DISCUSSION TO LAUNCH THE USDA'S NEW NUTRITION RESEARCH INITIATIVE: "AGRICULTURAL SCIENCE CENTER OF EXCELLENCE FOR NUTRITION AND DIET FOR BETTER HEALTH (ASCEND FOR BETTER HEALTH)," WEBINAR, DECEMBER 5, 2022. AICR VP OF RESEARCH PRESENTED A TALK ON "SCIENTIFIC RESEARCH ON LIFESTYLE CHOICES TO REDUCE YOUR CANCER RISK" CANCER HACKER LAB, PROSTATE CANCER LAB MEETING (VIRTUAL), JANUARY 18, 2023. AICR VP OF RESEARCH PRESENTED DURING A SYMPOSIUM ON "MEET THE FUNDERS: FUNDING OPPORTUNITIES FOR TRANSLATING BEHAVIORAL MEDICINE EVIDENCE INTO IMPACT" AT THE SOCIETY FOR BEHAVIORAL MEDICINE 44TH ANNUAL MEETING PHOENIX, AZ, APRIL 28, 2023. AICR VP OF RESEARCH PRESENTED TWO TALKS AT THE OGDEN SURGICAL-MEDICAL SOCIETY ANNUAL MEETING, OGDEN, UTAH: 1) "WHAT'S NEW IN MY SPECIALTY? BREAST CANCER PREVENTION AND 2) "CANCER PREVENTION RECOMMENDATIONS," OGDEN, UT, MAY 18 2023. RESEARCH PUBLICATIONS MANOCHA A, BROCKTON NT, COOK L, KOPCIUK KA. LOW SERUM VITAMIN D ASSOCIATED WITH INCREASED TUMOR SIZE AND HIGHER GRADE IN PREMENOPAUSAL CANADIAN WOMEN WITH BREAST CANCER. CLINICAL BREAST CANCER. 2023 AUG;23(6):E368-E376. AUNE D, MARKOZANNES G, ABAR L, BALDUCCI K, CARIOLOU M, NANU N, VIEIRA R, ANIFOWOSHE YO, GREENWOOD DC, CLINTON SK, GIOVANNUCCI EL, GUNTER MJ, JACKSON A, KAMPMAN E, LUND V, MCTIERNAN A, RIBOLI E, ALLEN K, BROCKTON NT, CROKER H, KATSIKIOTI D, MCGINLEY-GIESER D, MITROU P, WISEMAN M, VELIKOVA G, DEMARK-WAHNEFRIED W, NORAT T, TSILIDIS KK, CHAN DSM. PHYSICAL ACTIVITY AND HEALTH-RELATED QUALITY OF LIFE IN WOMEN WITH BREAST CANCER: A META-ANALYSIS. JNCI CANCER SPECTRUM. 2022 NOV 1;6(6). CARIOLOU M, ABAR L, AUNE D, BALDUCCI K, BECERRA-TOMS N, GREENWOOD DC, MARKOZANNES G, NANU N, VIEIRA R, GIOVANNUCCI EL, GUNTER MJ, JACKSON AA, KAMPMAN E, LUND V, ALLEN K, BROCKTON NT, CROKER H, KATSIKIOTI D, MCGINLEY-GIESER D, MITROU P, WISEMAN M, CROSS AJ, RIBOLI E, CLINTON SK, MCTIERNAN A, NORAT T, TSILIDIS KK, CHAN DSM. POSTDIAGNOSIS RECREATIONAL PHYSICAL ACTIVITY AND BREAST CANCER PROGNOSIS: GLOBAL CANCER UPDATE PROGRAMME (CUP GLOBAL) SYSTEMATIC LITERATURE REVIEW AND META-ANALYSIS. INTERNATIONAL JOURNAL OF CANCER. 2023 FEB 15;152(4):600-615. BECERRA-TOMS N, BALDUCCI K, ABAR L, AUNE D, CARIOLOU M, GREENWOOD DC, MARKOZANNES G, NANU N, VIEIRA R, GIOVANNUCCI EL, GUNTER MJ, JACKSON AA, KAMPMAN E, LUND V, ALLEN K, BROCKTON NT, CROKER H, KATSIKIOTI D, MCGINLEY-GIESER D, MITROU P, WISEMAN M, CROSS AJ, RIBOLI E, CLINTON SK, MCTIERNAN A, NORAT T, TSILIDIS KK, CHAN DSM. POSTDIAGNOSIS DIETARY FACTORS, SUPPLEMENT USE AND BREAST CANCER PROGNOSIS: GLOBAL CANCER UPDATE PROGRAMME (CUP GLOBAL) SYSTEMATIC LITERATURE REVIEW AND META-ANALYSIS. INTERNATIONAL JOURNAL OF CANCER. 2023 FEB 15;152(4):616-634. TSILIDIS KK, CARIOLOU M, BECERRA-TOMS N, BALDUCCI K, VIEIRA R, ABAR L, AUNE D, MARKOZANNES G, NANU N, GREENWOOD DC, GIOVANNUCCI EL, GUNTER MJ, JACKSON AA, KAMPMAN E, LUND V, ALLEN K, BROCKTON NT, CROKER H, KATSIKIOTI D, MCGINLEY-GIESER D, MITROU P, WISEMAN M, CROSS AJ, RIBOLI E, CLINTON SK, MCTIERNAN A, NORAT T, CHAN DSM POSTDIAGNOSIS BODY FATNESS, RECREATIONAL PHYSICAL ACTIVITY, DIETARY FACTORS AND BREAST CANCER PROGNOSIS: GLOBAL CANCER UPDATE PROGRAMME (CUP GLOBAL) SUMMARY OF EVIDENCE GRADING. INTERNATIONAL JOURNAL OF CANCER. 2023 FEB 15;152(4):635-644. |
| FORM 990, PART III, LINE 4B, CONTINUED. | CHAN DSM, VIEIRA R, ABAR L, AUNE D, BALDUCCI K, CARIOLOU M, GREENWOOD DC, MARKOZANNES G, NANU N, BECERRA-TOMS N, GIOVANNUCCI EL, GUNTER MJ, JACKSON AA, KAMPMAN E, LUND V, ALLEN K, BROCKTON NT, CROKER H, KATSIKIOTI D, MCGINLEY-GIESER D, MITROU P, WISEMAN M, CROSS AJ, RIBOLI E, CLINTON SK, MCTIERNAN A, NORAT T, TSILIDIS KK. POSTDIAGNOSIS BODY FATNESS, WEIGHT CHANGE AND BREAST CANCER PROGNOSIS: GLOBAL CANCER UPDATE PROGRAM (CUP GLOBAL) SYSTEMATIC LITERATURE REVIEW AND META-ANALYSIS. INTERNATIONAL JOURNAL OF CANCER. 2023 FEB 15;152(4):572-599. |
| FORM 990, PART VI, SECTION B, LINE 11B | THE 990 FORM IS PREPARED AND REVIEWED IN DETAIL BY KEY STAFF IN THE AICR ACCOUNTING DEPARTMENT. THE 990 FORM IS THEN REVIEWED BY AICR EXECUTIVE MANAGEMENT, RSM TAX AND THE LAW FIRM STEPTOE & JOHNSON. RSM TAX AND STEPTOE & JOHNSON BOTH CONDUCT DETAILED REVIEWS OF THE 990 FORM. ONCE THE 990 FORM AND ACCOMPANYING SCHEDULES ARE IN FINAL DRAFT FORM, THE AICR BOARD OF DIRECTORS ARE ASKED TO REVIEW AND PROVIDE FEEDBACK PRIOR TO THE FILING. |
| FORM 990, PART VI, SECTION B, LINE 12C | THE INSTITUTE'S BOARD OF DIRECTORS HAS A CONFLICT OF INTEREST POLICY IN EFFECT. A COPY OF THE POLICY IS PROVIDED TO EACH DIRECTOR, OFFICER AND STAFF MEMBER OF AICR WHO IS PRESENTLY SERVING IN A CAPACITY WHERE A CONFLICT OF INTEREST COULD ARISE. THE POLICY IS REVIEWED ANNUALLY. IF THE BOARD DETERMINES THAT CHANGES DO NOT NEED TO BE MADE, THE POLICY IS REAFFIRMED. NEW DIRECTORS, OFFICERS, AND STAFF MEMBERS ARE ADVISED OF THE POLICY IN EFFECT UPON TAKING OFFICE OR UPON THE START OF EMPLOYMENT, AS THE CASE MAY BE. SINCE FISCAL YEAR 2010, DIRECTORS, OFFICERS, EXECUTIVES, AND SENIOR LEVEL MANAGEMENT STAFF HAVE BEEN REQUIRED TO SIGN A "DECLARATION OF LACK OF CONFLICT OF INTEREST." THE POLICY PROVIDES THAT IN THE EVENT OF A CONFLICT OF INTEREST RELEVANT TO A MATTER REQUIRING ACTION BY THE BOARD, THE PERSON SHALL CALL IT TO THE ATTENTION OF THE BOARD (OR COMMITTEE OF THE BOARD, AS THE CASE MAY BE), AND SUCH PERSON SHALL NOT VOTE ON THE MATTER. THE PERSON HAVING A CONFLICT OF INTEREST SHALL PROVIDE THE BOARD (OR COMMITTEE OF THE BOARD, AS THE CASE MAY BE), WITH ANY AND ALL RELEVANT INFORMATION, AND SHALL RETIRE FROM THE ROOM IN WHICH THE BOARD (OR COMMITTEE OF THE BOARD, AS THE CASE MAY BE) IS MEETING CONCERNING SUCH MATTER, AND SHALL NOT PARTICIPATE IN THE FINAL DELIBERATION OR DECISION REGARDING THE MATTER UNDER CONSIDERATION. THE MINUTES OF THE MEETING OF THE BOARD (OR COMMITTEE OF THE BOARD, AS THE CASE MAY BE) SHALL REFLECT THAT THE CONFLICT OF INTEREST WAS DISCLOSED AND THAT THE INTERESTED PERSON WAS NOT PRESENT DURING THE FINAL DISCUSSION OF SUCH MATTER OR VOTE AND DID NOT VOTE ON SUCH MATTER. WHEN THERE IS A DOUBT AS TO WHETHER A CONFLICT OF INTEREST EXISTS, THE MATTER SHALL BE RESOLVED BY VOTE OF THE BOARD OF DIRECTORS (OR COMMITTEE OF THE BOARD, AS THE CASE MAY BE), EXCLUDING THE INTERESTED PERSON. |
| FORM 990, PART VI, SECTION B, LINE 15 | THE COMPENSATION COMMITTEE, THROUGH A RESOLUTION OF THE AICR BOARD OF DIRECTORS, IS RESPONSIBLE FOR SETTING THE COMPENSATION OF THE PRINCIPAL OFFICERS. THIS COMMITTEE CONDUCTS AN ANNUAL REVIEW OF PERFORMANCE AT THE END OF EACH CALENDAR YEAR AGAINST THE GOALS AND OBJECTIVES ESTABLISHED IN THE YEARLY BUDGETS, THE YEARLY OPERATION PLAN AND THE LONG-TERM STRATEGIC PLANS. INFORMATION UTILIZED IN DETERMINING COMPENSATION ADJUSTMENTS FOR THIS REPORTING PERIOD INCLUDE: 1) REPORT FROM THE EXECUTIVE TEAM FOR THE CALENDAR YEAR; 2) FISCAL YEAR PERFORMANCE AND EFFECTIVENESS ASSESSMENT REPORT; 3) HRA-NCA COMPENSATION SURVEY; 4) AMERICAN SOCIETY OF ASSOCIATION EXECUTIVES ASSOCIATION COMPENSATION AND BENEFITS REPORT; 5) GUIDESTAR COMPENSATION REPORT 5) NONPROFIT TIMES NONPROFIT SALARY AND BENEFITS REPORT. AFTER REVIEWING COMPENSATION STUDIES AND OTHER INDUSTRY INFORMATION, COMPENSATION IS DETERMINED AND AWARDED. INCREASES ARE CONSISTENT WITH COMPENSATION PAID BY ORGANIZATIONS SIMILAR TO AICR HAVING COMPARABLE RESPONSIBILITY AND DUTIES. INCREASES ARE DOCUMENTED AND A MEMO IS DRAFTED FROM THE COMPENSATION COMMITTEE TO THE SENIOR VICE PRESIDENT OF FINANCE, HUMAN RESOURCE FILE AND TO THE EXECUTIVES RECEIVING THE REVIEW INCLUDING THE INSTRUCTIONS AND DETAILS FOR THE COMPENSATION CHANGES. |
| FORM 990, PART VI, SECTION C, LINE 19 | ALL GOVERNING DOCUMENTS AND FINANCIAL STATEMENTS ARE AVAILABLE TO THE PUBLIC UPON REQUEST FOR THE SAME PERIOD OF DISCLOSURE AS SET FORTH IN SECTION 6104(D). |
| FORM 990, PART XI, LINE 9: | CHANGE IN VALUE OF SPLIT INTEREST AGREEMENT LIABILITY 69,342. NET GAIN ON INTEREST IN PERPETUAL TRUST 3,680. |
| FORM 990, PART XII, LINE 2C: | THE PROCESS FOR OVERSEEING THE AUDIT OF THE FINANCIAL STATEMENTS AND SELECTION OF AN INDEPENDENT ACCOUNTANT THAT AUDITED THE FINANCIAL STATEMENTS HAS BEEN CONSISTENT WITH PRIOR YEARS. |
| Software ID: | |
| Software Version: |